Gotham Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-13,990
| Closed | -$720K | – | 1097 |
|
|
2020
Q1 | $720K | Sell |
13,990
-15,489
| -53% | -$797K | 0.02% | 638 |
|
|
2019
Q4 | $1.82M | Sell |
29,479
-11,091
| -27% | -$685K | 0.03% | 490 |
|
|
2019
Q3 | $2.44M | Buy |
40,570
+8,225
| +25% | +$494K | 0.04% | 420 |
|
|
2019
Q2 | $2.73M | Buy |
32,345
+13,693
| +73% | +$1.16M | 0.04% | 436 |
|
|
2019
Q1 | $1.78M | Sell |
18,652
-3,830
| -17% | -$366K | 0.03% | 516 |
|
|
2018
Q4 | $1.59M | Sell |
22,482
-7,752
| -26% | -$549K | 0.02% | 547 |
|
|
2018
Q3 | $2.58M | Buy |
30,234
+15,062
| +99% | +$1.29M | 0.04% | 457 |
|
|
2018
Q2 | $1.76M | Sell |
15,172
-77
| -0.5% | -$8.92K | 0.03% | 495 |
|
|
2018
Q1 | $1.23M | Buy |
15,249
+3,973
| +35% | +$322K | 0.02% | 579 |
|
|
2017
Q4 | $662K | Sell |
11,276
-836
| -7% | -$49.1K | 0.01% | 664 |
|
|
2017
Q3 | $567K | Sell |
12,112
-7,156
| -37% | -$335K | 0.01% | 680 |
|
|
2017
Q2 | $693K | Sell |
19,268
-19,313
| -50% | -$695K | 0.01% | 692 |
|
|
2017
Q1 | $1.19M | Sell |
38,581
-12,048
| -24% | -$371K | 0.02% | 637 |
|
|
2016
Q4 | $1.7M | Sell |
50,629
-17,885
| -26% | -$599K | 0.02% | 533 |
|
|
2016
Q3 | $1.82M | Sell |
68,514
-42,722
| -38% | -$1.14M | 0.02% | 511 |
|
|
2016
Q2 | $2.45M | Buy |
111,236
+22,605
| +26% | +$498K | 0.03% | 498 |
|
|
2016
Q1 | $2.6M | Buy |
+88,631
| New | +$2.6M | 0.03% | 540 |
|
|
2015
Q4 | – | Sell |
-311,850
| Closed | -$11.3M | – | 897 |
|
|
2015
Q3 | $11.3M | Buy |
311,850
+197,318
| +172% | +$7.13M | 0.11% | 274 |
|
|
2015
Q2 | $5.15M | Buy |
114,532
+66,661
| +139% | +$3M | 0.04% | 445 |
|
|
2015
Q1 | $1.47M | Buy |
47,871
+36,504
| +321% | +$1.12M | 0.01% | 551 |
|
|
2014
Q4 | $578K | Sell |
11,367
-40,863
| -78% | -$2.08M | ﹤0.01% | 710 |
|
|
2014
Q3 | $2.07M | Buy |
+52,230
| New | +$2.07M | 0.02% | 528 |
|